Camber Spine reports 36% growth in 2018: 4 things to know

Laura Dyrda -   Print  |

Camber Spine released preliminary financial results for 2018.

The primary unaudited proprietary sales results show:

1. Fourth quarter sales grew 38 percent year over year, while full-year sales were up 36 percent over 2017. The company attributed growth to increased use of SPIRA and ENZA, Camber's proprietary technology platforms.

2. In 2018, SPIRA and ENZA sales grew 271 percent, and Camber added 60 new surgeon users.

3. Over the past year, Camber Spine launched four new products, including a cervical interbody device, anatomic oblique TLIF system and the second generation of its ENZA-A Titanium 3D-printed MIS ALIF.

4. The company expects more proprietary sales growth in 2019 with additional product launches and three new products outside of the core platforms.

More articles on orthopedic surgery:
Stryker, Zimmer Biomet, Medtronic & more: 12 device company notes
Mako total knee procedures up 35% in 2018, Stryker expects double-digit installations in 2019
DePuy Synthes creates new jobs in Ireland with investment: 3 details

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers